Unbiased Insight on Biopharma’s Innovation Crisis

by | May 2008

The pharmaceutical industry is at a crossroads. In 2010, it faces one of the biggest waves of proprietary patent expirations yet lacks a viable pipeline to replace these soon to be generics. Furthermore, R&D expenditures have more than doubled from 1995 to 2006...

Sector inquiry into the pharmaceutical sector

by | Jan 2008

Introduction More than 8 months ago (on 15 January 2008) the European Commission (“Commission“) launched a sector inquiry into the pharmaceutical sector relating to the introduction of innovative and generic medicines for human consumption onto the market. The...